Giraudo Bryan — SEC insider filings

SEC reporting owner CIK 1740847. 29 insider filings on record with FilingPulse; latest filed 2026-08-26.

Transaction summary — filings shown

Covers all 29 filings on record, filed 2020-10-14 to 2026-08-26. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Protagonist Therapeutics, Inc (PTGX)Director7—4 legs · 59,130 sh · $5,918,88012
Gossamer Bio, Inc. (GOSS)COO/CFO226 legs · 421,869 sh · $406,5513 legs · 22,642 sh · $155,06348

Insider filings — Giraudo Bryan

FiledFormIssuerReported transactionsSource
2026-08-264Gossamer Bio, Inc. (GOSS)Grant/award (A): 25 (derivative) @ $1,000.00 · Grant/award (A): 5,800,051 (derivative) @ $0EDGAR
2026-05-114Protagonist Therapeutics, Inc (PTGX)Option exercise (M): 24,000 @ $6.45 · Option exercise (M): 12,000 @ $6.98 · Sale (S): 36,000 @ $100.14 · Sale (S): 12,000 @ $100.07 · Sale (S): 6,000 @ $100 · Sale (S): 5,130 @ $100 · +2 moreEDGAR
2026-03-204Gossamer Bio, Inc. (GOSS)Disposition to issuer (D): 693,750 (derivative) · Disposition to issuer (D): 638,000 (derivative) · Disposition to issuer (D): 543,750 (derivative) · Disposition to issuer (D): 181,250 (derivative) · Disposition to issuer (D): 211,500 (derivative) · Disposition to issuer (D): 211,500 (derivative) · +16 moreEDGAR
2026-01-064Protagonist Therapeutics, Inc (PTGX)Grant/award (A): 2,695 @ $0 · Grant/award (A): 3,762 (derivative) @ $0EDGAR
2026-01-054Gossamer Bio, Inc. (GOSS)Grant/award (A): 115,750 @ $0 · Grant/award (A): 693,750 (derivative) @ $0EDGAR
2025-10-024Gossamer Bio, Inc. (GOSS)Grant/award (A): 181,250 @ $0EDGAR
2025-03-064Gossamer Bio, Inc. (GOSS)Grant/award (A): 638,000 (derivative) @ $0EDGAR
2025-01-064Protagonist Therapeutics, Inc (PTGX)Grant/award (A): 5,130 @ $0 · Grant/award (A): 6,584 (derivative) @ $0EDGAR
2024-06-204Gossamer Bio, Inc. (GOSS)Purchase (P): 100,000 @ $0.59EDGAR
2024-03-284Gossamer Bio, Inc. (GOSS)Sale (S): 6,430 @ $1.16EDGAR
2024-01-044Protagonist Therapeutics, Inc (PTGX)Grant/award (A): 25,700 (derivative) @ $0EDGAR
2024-01-044Gossamer Bio, Inc. (GOSS)Grant/award (A): 543,750 (derivative) @ $0EDGAR
2023-11-224Gossamer Bio, Inc. (GOSS)Grant/award (A): 181,250 (derivative) @ $0EDGAR
2023-11-144Gossamer Bio, Inc. (GOSS)Purchase (P): 200,000 @ $0.56EDGAR
2023-07-264Gossamer Bio, Inc. (GOSS)Grant/award (A): 54,020 @ $1.82 · Grant/award (A): 13,505 (derivative) @ $0.12EDGAR
2023-05-094Gossamer Bio, Inc. (GOSS)Disposition to issuer (D): 145,000 (derivative) · Disposition to issuer (D): 71,500 (derivative) · Disposition to issuer (D): 90,000 (derivative) · Disposition to issuer (D): 150,000 (derivative) · Disposition to issuer (D): 265,000 (derivative) · Grant/award (A): 96,667 (derivative) · +4 moreEDGAR
2023-04-054Gossamer Bio, Inc. (GOSS)Purchase (P): 55,000 @ $1.02EDGAR
2023-03-224Gossamer Bio, Inc. (GOSS)Purchase (P): 50,000 @ $0.97 · Grant/award (A): 211,500 (derivative) @ $0EDGAR
2023-01-184Protagonist Therapeutics, Inc (PTGX)Grant/award (A): 30,000 (derivative) @ $0EDGAR
2022-12-094Gossamer Bio, Inc. (GOSS)Grant/award (A): 211,500 (derivative) @ $0EDGAR
2022-07-154Gossamer Bio, Inc. (GOSS)Purchase (P): 13,869 @ $7.21EDGAR
2022-05-274Protagonist Therapeutics, Inc (PTGX)Grant/award (A): 20,000 (derivative) @ $0EDGAR
2022-03-244Gossamer Bio, Inc. (GOSS)Sale (S): 10,722 @ $8.91EDGAR
2022-01-104Gossamer Bio, Inc. (GOSS)Grant/award (A): 265,000 (derivative) @ $0EDGAR
2021-09-204Gossamer Bio, Inc. (GOSS)Grant/award (A): 150,000 (derivative) @ $0EDGAR
2021-05-284Protagonist Therapeutics, Inc (PTGX)Grant/award (A): 18,000 (derivative) @ $0EDGAR
2021-03-254Gossamer Bio, Inc. (GOSS)Sale (S): 5,490 @ $9.48EDGAR
2021-03-014Gossamer Bio, Inc. (GOSS)Grant/award (A): 45,000 @ $0 · Grant/award (A): 90,000 (derivative) @ $0EDGAR
2020-10-144Gossamer Bio, Inc. (GOSS)Purchase (P): 3,000 @ $10.01EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-10-13 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1740847 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs